Article
Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells.
Nature - 1 Oct 2020
Bao Erik L, Nandakumar Satish K, Liao Xiaotian, Bick Alexander G, Karjalainen Juha, Tabaka Marcin, Gan Olga I, Havulinna Aki S, Kiiskinen Tuomo T J, Lareau Caleb A, de Lapuente Portilla Aitzkoa L, Li Bo, Emdin Connor, Codd Veryan, Nelson Christopher P, Walker Christopher J, Churchhouse Claire, de la Chapelle Albert, Klein Daryl E, Nilsson Björn, Wilson Peter W F, Cho Kelly, Pyarajan Saiju, Gaziano J Michael, Samani Nilesh J, Regev Aviv, Palotie Aarno, Neale Benjamin M, Dick John E, Natarajan Pradeep, O'Donnell Christopher J, Daly Mark J, Milyavsky Michael, Kathiresan Sekar, Sankaran Vijay G
Abstract excerpt
Myeloproliferative neoplasms (MPNs) are blood cancers that are characterized by the excessive production of mature myeloid cells and arise from the acquisition of somatic driver mutations in haematopoietic stem cells (HSCs). Epidemiological studies indicate a substantial heritable component of MPNs that is among the highest known for cancers1. However, only a limited number of genetic risk loci have been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
